Mark Dybul
2021
In 2021, Mark Dybul earned a total compensation of $430K as Chief Executive Officer at Enochian Biosciences, a 66% decrease compared to previous year.
Compensation breakdown
| Salary | $430,000 |
|---|---|
| Total | $430,000 |
Dybul received $430K in salary, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Mark Dybul's compensation ranked 11,036th out of 12,415 executives tracked by ExecPay. In other words, Dybul earned more than 11.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,036 out of 12,415 | 11th |
Division Manufacturing | 4,870 out of 5,508 | 12th |
Major group Chemicals And Allied Products | 2,174 out of 2,378 | 9th |
Industry group Drugs | 1,935 out of 2,099 | 8th |
Industry Pharmaceutical Preparations | 1,434 out of 1,549 | 7th |
Source: SEC filing on January 27, 2022.
Dybul's colleagues
We found one more compensation record of an executive who worked with Mark Dybul at Enochian Biosciences in 2021.
2021
Luisa Puche
Enochian Biosciences